The Wall Street Journal reports that Boston’s once-booming biotech sector has hit a sharp downturn, leaving newly minted Ph.D.s struggling to find work as venture funding dries up, lab space sits empty, and companies downsize or relocate amid rising costs and policy uncertainty. The Wall Street Journal reports: Boston’s biotech sector, long a vital economic engine for one of America’s wealthiest metro areas, is sputtering. A double whammy of cutbacks in venture capital and…
